@nationglass9
Active 1 month ago
The drug may enhance hypoglycemic agents by slowing their clearance, heightening the risk of symptomatic hypoglycemia in insulin- or sulfonylurea-treated patients. Clinically consequential interactions center on hepatic enzyme modulation and additive physiologic effects. Additional absolute contraindications include nephrosis, the nephrotic […] View